Latest On PRA Health Sciences, Inc (PRAH):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-04-28 20:47 EST | News | PRA Health Sciences EPS beats by $0.02, beats on revenue | N/A |  |
| 2021-04-16 00:43 EST | News | Syneos Health gains following Thermo Fisher $17B deal for PPD | N/A | |
| 2021-04-16 00:42 EST | News | Icon wins U.S. antitrust approval for PRA Health acquisition | N/A | |
| 2021-04-15 06:43 EST | News | PPD gains after report Thermo Fisher nearing $15B deal | N/A | |
| 2021-04-13 18:51 EST | News | PRA Health selected by Maryland State to supply remote patient monitoring services | N/A | |
| 2021-04-07 20:19 EST | News | PRA Health and Merck KGaA team up for human growth hormone treatment system | N/A | |
| 2021-04-01 21:53 EST | News | Wells Fargo upgrades ICON to overweight, sees ~20% upside | N/A | |
| 2021-03-09 12:17 EST | Analyst Rating | The Analyst Target Price has increased from $147.4 to $149.33. | Buy | |
| 2021-03-06 00:59 EST | News | Icon upped to hold from sell at CFRA citing recent underperformance | N/A | |
| 2021-03-03 12:17 EST | Analyst Rating | The Analyst Target Price has increased from $144.7 to $147.4. | Buy | |
| 2021-03-01 12:12 EST | Analyst Rating | The Analyst Target Price has increased from $139.4 to $144.7. | Neutral | |
| 2021-02-27 00:27 EST | News | PRA Health Sciences, Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-02-26 16:11 EST | Analyst Rating | The Analyst Target Price has increased from $127.42 to $139.4. | Neutral | |
| 2021-02-25 21:46 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-25 14:18 EST | Earnings Estimate | An EPS average of $1.41 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-02-25 14:18 EST | Earnings Estimate | An EPS average of $6.62 is estimated for the 2022 year. | Buy | |
| 2021-02-24 13:09 EST | News | PRA Health Sciences EPS beats by $0.09, beats on revenue | N/A | |
| 2021-02-24 13:09 EST | News | ICON to acquire PRA Health in a cash and stock deal valued at $12B | N/A | |
| 2021-02-24 13:08 EST | News | LabCorp sum-of-the-parts worth $313/share with activist push, analyst says | N/A | |
| 2021-02-24 13:08 EST | News | William Blair sees 'very complementary fit' with ICON acquisition of PRA Health | N/A | |
| 2021-01-27 08:18 EST | Analyst Rating | The Analyst Target Price has increased from $126.75 to $127.42. | Neutral | |
| 2021-01-21 12:33 EST | Analyst Rating | The Analyst Target Price has increased from $125.5 to $126.75. | Neutral | |
| 2021-01-13 08:25 EST | Analyst Rating | The Analyst Target Price has increased from $125.17 to $125.5. | Neutral | |
| 2021-01-11 12:28 EST | Analyst Rating | The Analyst Target Price has increased from $124.75 to $125.17. | Neutral | |
| 2021-01-08 12:25 EST | Analyst Rating | The Analyst Target Price has increased from $122.92 to $124.75. | Neutral | |
| 2020-12-03 12:32 EST | Analyst Rating | The Analyst Target Price has increased from $122.77 to $122.92. | Buy | |
| 2020-11-26 21:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 05:08 EST | Analyst Rating | The Analyst Target Price has increased from $121.23 to $122.77. | Buy | |
| 2020-11-11 04:45 EST | Analyst Rating | The Analyst Target Price has increased from $119.62 to $121.23. | Buy | |
| 2020-11-09 20:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 13:06 EST | Analyst Rating | The Analyst Target Price has increased from $117.23 to $119.62. | Buy | |
| 2020-11-08 00:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 14:59 EST | News | PRA Health Sciences, Inc. 2020 Q3 - Results - Earnings Call Presentation | N/A | |
| 2020-11-07 14:58 EST | News | PRA Health Sciences, Inc. (PRAH) CEO Colin Shannon on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-06 12:32 EST | Analyst Rating | The Analyst Target Price has increased from $114.38 to $117.23. | Buy | |
| 2020-11-05 13:05 EST | News | PRA Health Sciences EPS beats by $0.16, beats on revenue; FY20 guidance | N/A | |
| 2020-11-05 13:00 EST | Earnings Estimate | An EPS average of $1.27 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-05 12:59 EST | Analyst Rating | The Analyst Target Price has increased from $113.77 to $114.38. | Neutral | |
| 2020-10-30 14:20 EST | Analyst Rating | The Analyst Target Price has increased from $113.46 to $113.77. | Buy | |
| 2020-10-08 10:00 EST | Analyst Rating | The Analyst Target Price has increased from $113.23 to $113.46. | Buy | |
| 2020-10-06 09:50 EST | Analyst Rating | The Analyst Target Price has decreased from $113.62 to $113.23. | Neutral | |
| 2020-09-26 13:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-22 05:57 EST | News | PRA Health Sciences: A Solid Investment Case But Watch Out For Signs Of Inertia | N/A | |
| 2020-09-18 14:53 EST | News | PRA Health and Deep Lens partner to accelerate patient recruitment | N/A | |
| 2020-09-17 05:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-16 17:43 EST | Insider Trade | Glen D. Stettin has directly acquired 799 shares and currently holds 799 shares. | Buy | |
| 2020-08-17 16:30 EST | Insider Trade | Michael J. Bonello has directly disposed of 2,052 shares and currently holds 21,276 shares. | Sell | |
| 2020-08-17 16:30 EST | Insider Trade | Christopher L Gaenzle has directly disposed of 1,364 shares and currently holds 37,636 shares. | Sell | |
| 2020-08-17 16:30 EST | Insider Trade | COLIN SHANNON has directly disposed of 6,073 shares and currently holds 56,927 shares. | Sell | |
About PRA Health Sciences, Inc (PRAH):
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that allow clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.
General
- Name PRA Health Sciences, Inc
- Symbol PRAH
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 18,100
- Fiscal Year EndDecember
- IPO Date2014-11-13
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryLife Sciences Tools & Services
- Gic SubIndustryLife Sciences Tools & Services
- Web URLhttp://prahs.com
View More
Valuation
- Trailing PE 48.08
- Forward PE 24.75
- Price/Sales (Trailing 12 Mt.) 2.96
- Price/Book (Most Recent Quarter) 6.35
- Enterprise Value Revenue 3.25
- Enterprise Value EBITDA 23.88
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $5.81
- Next Year EPS Estimate $6.60
- Next Quarter EPS Estimate $1.32
- Profit Margin 6%
- Operating Margin 9%
- Return on Assets 5%
- Return on Equity 15%
- Revenue 3.18 billion
- Earnings Per Share $3.04
- Revenue Per Share $50.25
- Gross Profit 1.53 billion
- Quarterly Earnings Growth 9.1%
View More
Highlights
- Market Capitalization 9.43 billion
- EBITDA 415.57 million
- PEG Ratio 1.85
- Analyst Target Price $149.33
- Book Value Per Share $22.92
View More
Share Statistics
- Shares Outstanding 64.54 million
- Shares Float 64.37 million
- % Held by Insiders 24%
- % Held by Institutions 98.91%
- Shares Short 853901
- Shares Short Prior Month 748886
- Short Ratio 1.15
- Short % of Float 2%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 1.27
- 52 Week High $150.82
- 52 Week Low $58.67
- 50 Day Moving Average 134.39
- 200 Day Moving Average 118.07
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
PRA Health Sciences, Inc (PRAH) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
PRA Health Sciences, Inc (PRAH) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $N/A | $1.55 | $1.46 | 6.46% |
| 2020-09-30 | 2020-11-04 | $796.28 million | $1.30 | $1.14 | 14.07% |
| 2020-06-30 | 2020-08-06 | $N/A | $0.86 | $0.82 | 4.5% |
| 2020-03-31 | 2020-04-30 | $N/A | $1.05 | $1.00 | 5.34% |
| 2019-12-31 | 2020-02-20 | $800.24 million | $1.54 | $1.47 | 4.63% |
| 2019-09-30 | 2019-10-30 | $780.69 million | $1.32 | $1.29 | 2.31% |
| 2019-06-30 | 2019-07-31 | $763.31 million | $1.22 | $1.17 | 4.09% |
| 2019-03-31 | 2019-05-01 | $722.02 million | $1.10 | $1.06 | 3.65% |
| 2018-12-31 | 2019-02-27 | $729.65 million | $1.31 | $1.27 | 3.28% |
| 2018-09-30 | 2018-10-31 | $717.6 million | $1.13 | $1.07 | 5.27% |
| 2018-06-30 | 2018-08-01 | $722.84 million | $1.00 | $0.95 | 5.35% |
| 2018-03-31 | 2018-04-25 | $701.84 million | $0.85 | $0.84 | 1.52% |
| 2017-12-31 | 2018-02-21 | $655.9 million | $1.04 | $1.02 | 1.49% |
| 2017-09-30 | 2017-10-25 | $582.01 million | $0.88 | $0.85 | 3.98% |
| 2017-06-30 | 2017-08-07 | $533.72 million | $0.79 | $0.74 | 6.54% |
| 2017-03-31 | 2017-04-25 | $487.76 million | $0.62 | $0.60 | 3.14% |
| 2016-12-31 | 2017-02-22 | $472.39 million | $0.71 | $0.64 | 10.71% |
| 2016-09-30 | 2016-11-02 | $453.26 million | $0.64 | $0.63 | 0.87% |
| 2016-06-30 | 2016-07-28 | $455.85 million | $0.63 | $0.59 | 7.47% |
| 2016-03-31 | 2016-04-27 | $430.22 million | $0.55 | $0.53 | 3.79% |
| 2015-12-31 | 2016-02-24 | $428.95 million | $0.59 | $0.50 | 17.02% |
| 2015-09-30 | 2015-11-02 | $403.51 million | $0.52 | $0.45 | 15.56% |
| 2015-06-30 | 2015-07-27 | $392.85 million | $0.47 | $0.40 | 17.5% |
| 2015-03-31 | 2015-05-06 | $388.58 million | $0.41 | $0.31 | 32.26% |
| 2014-12-31 | 2015-02-18 | $369.96 million | $0.35 | $0.30 | 16.67% |
PRA Health Sciences, Inc (PRAH) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
PRA Health Sciences, Inc (PRAH) Chart:
PRA Health Sciences, Inc (PRAH) News:
Below you will find a list of latest news for PRA Health Sciences, Inc (PRAH) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
PRA Health Sciences, Inc (PRAH) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
PRA Health Sciences, Inc (PRAH) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920069440/0001104659-20-069440-index.htm |
| 2018-10-31 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1613859/000000000018033979/0000000000-18-033979-index.htm |
| 2018-11-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1613859/000000000018034843/0000000000-18-034843-index.htm |
| 2019-10-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000008025519002969/0000080255-19-002969-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000008025520001277/0000080255-20-001277-index.htm |
| 2018-02-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000021545718004721/0000215457-18-004721-index.htm |
| 2018-06-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000021545718005685/0000215457-18-005685-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000021545719005002/0000215457-19-005002-index.htm |
| 2019-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000083423719000382/0000834237-19-000382-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000083423720002824/0000834237-20-002824-index.htm |
| 2020-01-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000090221920000201/0000902219-20-000201-index.htm |
| 2018-02-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000093247118004056/0000932471-18-004056-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000093247119006033/0000932471-19-006033-index.htm |
| 2018-04-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1613859/000104746918003013/0001047469-18-003013-index.htm |
| 2018-08-07 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1613859/000104746918005435/0001047469-18-005435-index.htm |
| 2018-08-08 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1613859/000104746918005508/0001047469-18-005508-index.htm |
| 2019-03-06 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1613859/000104746919000948/0001047469-19-000948-index.htm |
| 2019-04-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1613859/000104746919002379/0001047469-19-002379-index.htm |
| 2019-09-04 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1613859/000104746919004946/0001047469-19-004946-index.htm |
| 2019-09-05 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1613859/000104746919005017/0001047469-19-005017-index.htm |
| 2019-09-13 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1613859/000104746919005229/0001047469-19-005229-index.htm |
| 2020-04-03 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1613859/000104746920002068/0001047469-20-002068-index.htm |
| 2017-11-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1613859/000110465917065160/0001104659-17-065160-index.htm |
| 2017-11-13 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465917067943/0001104659-17-067943-index.htm |
| 2017-11-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465917069448/0001104659-17-069448-index.htm |
| 2017-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465917074637/0001104659-17-074637-index.htm |
| 2017-12-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465917075713/0001104659-17-075713-index.htm |
| 2018-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm |
| 2018-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm |
| 2018-04-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465918024903/0001104659-18-024903-index.htm |
| 2018-04-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1613859/000110465918025621/0001104659-18-025621-index.htm |
| 2018-04-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465918026604/0001104659-18-026604-index.htm |
| 2018-05-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465918029351/0001104659-18-029351-index.htm |
| 2018-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465918029352/0001104659-18-029352-index.htm |
| 2018-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465918037085/0001104659-18-037085-index.htm |
| 2018-05-31 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1613859/000110465918037121/0001104659-18-037121-index.htm |
| 2018-05-31 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1613859/000110465918037123/0001104659-18-037123-index.htm |
| 2018-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465918038150/0001104659-18-038150-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465918042047/0001104659-18-042047-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465918042048/0001104659-18-042048-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465918042049/0001104659-18-042049-index.htm |
| 2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465918042050/0001104659-18-042050-index.htm |
| 2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465918050976/0001104659-18-050976-index.htm |
| 2018-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000110465918052811/0001104659-18-052811-index.htm |
| 2018-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465918052812/0001104659-18-052812-index.htm |
| 2018-11-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1613859/000110465918066242/0001104659-18-066242-index.htm |
| 2019-04-18 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1613859/000110465919022339/0001104659-19-022339-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465919034062/0001104659-19-034062-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465919034064/0001104659-19-034064-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465919034065/0001104659-19-034065-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465919034066/0001104659-19-034066-index.htm |
| 2019-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465919046055/0001104659-19-046055-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465919046966/0001104659-19-046966-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465919046967/0001104659-19-046967-index.htm |
| 2019-09-04 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1613859/000110465919048481/0001104659-19-048481-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000110465920017131/0001104659-20-017131-index.htm |
| 2020-03-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920029723/0001104659-20-029723-index.htm |
| 2020-04-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1613859/000110465920043152/0001104659-20-043152-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920052387/0001104659-20-052387-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064309/0001104659-20-064309-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064310/0001104659-20-064310-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064311/0001104659-20-064311-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064312/0001104659-20-064312-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064314/0001104659-20-064314-index.htm |
| 2020-05-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1613859/000110465920065894/0001104659-20-065894-index.htm |
| 2020-05-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1613859/000110465920065895/0001104659-20-065895-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920069438/0001104659-20-069438-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920069439/0001104659-20-069439-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920069440/0001104659-20-069440-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920096108/0001104659-20-096108-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920096109/0001104659-20-096109-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920096111/0001104659-20-096111-index.htm |
| 2020-09-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920105711/0001104659-20-105711-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000110465920105715/0001104659-20-105715-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000114036118007240/0001140361-18-007240-index.htm |
| 2018-07-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000114036118030961/0001140361-18-030961-index.htm |
| 2018-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000114036118030997/0001140361-18-030997-index.htm |
| 2018-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000114036118036243/0001140361-18-036243-index.htm |
| 2018-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000114036118036244/0001140361-18-036244-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000114036119003050/0001140361-19-003050-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000114036119016469/0001140361-19-016469-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1613859/000114036119016474/0001140361-19-016474-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000114036120003236/0001140361-20-003236-index.htm |
| 2019-10-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000114420419047874/0001144204-19-047874-index.htm |
| 2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000141057819001013/0001410578-19-001013-index.htm |
| 2019-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000141057819001086/0001410578-19-001086-index.htm |
| 2019-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000141057819001235/0001410578-19-001235-index.htm |
| 2018-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000142284818000354/0001422848-18-000354-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000142284819000095/0001422848-19-000095-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1613859/000142284820000079/0001422848-20-000079-index.htm |
| 2018-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385918000005/0001613859-18-000005-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000161385918000007/0001613859-18-000007-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000006/0001613859-19-000006-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/0001613859-19-000008-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000014/0001613859-19-000014-index.htm |
| 2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000016/0001613859-19-000016-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000018/0001613859-19-000018-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000022/0001613859-19-000022-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000025/0001613859-19-000025-index.htm |
| 2019-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000028/0001613859-19-000028-index.htm |
| 2019-10-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000031/0001613859-19-000031-index.htm |
| 2019-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385919000035/0001613859-19-000035-index.htm |
| 2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000004/0001613859-20-000004-index.htm |
| 2020-02-21 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/0001613859-20-000007-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000010/0001613859-20-000010-index.htm |
| 2020-05-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000012/0001613859-20-000012-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000014/0001613859-20-000014-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000018/0001613859-20-000018-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000020/0001613859-20-000020-index.htm |
| 2020-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000025/0001613859-20-000025-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000030/0001613859-20-000030-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000161385920000032/0001613859-20-000032-index.htm |
| 2018-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000162828018001965/0001628280-18-001965-index.htm |
| 2018-02-22 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/0001628280-18-002026-index.htm |
| 2018-04-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000162828018004985/0001628280-18-004985-index.htm |
| 2018-04-26 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000162828018005099/0001628280-18-005099-index.htm |
| 2018-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1613859/000162828018010186/0001628280-18-010186-index.htm |
| 2018-08-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1613859/000162828018010277/0001628280-18-010277-index.htm |
PRA Health Sciences, Inc (PRAH) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PRA Health Sciences, Inc (PRAH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 24%Institutional Ownership: 9891%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2017-12-28 | David W Dockhorn | Executive Vice President & CCO | Sell | 4,236.00 | 91.22 | 386,407.92 | 0.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm |
| 2018-01-16 | LINDA BADDOUR | Executive VP & CFO | Sell | 2,595.00 | 90.56 | 235,003.20 | 0.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm |
| 2017-11-16 | Matthew P. Young | Director | Sell | 5,115.00 | 79.90 | 408,688.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465917069448/0001104659-17-069448-index.htm |
| 2018-06-21 | Jeffrey T Barber | Director | Buy | 1,307.00 | 11,719.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918042048/0001104659-18-042048-index.htm | ||
| 2019-06-03 | Jeffrey T Barber | Director | Buy | 1,436.00 | 13,155.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465919034062/0001104659-19-034062-index.htm | ||
| 2019-08-13 | JAMES C MOMTAZEE | Director | Buy | 1,443.00 | 1,443.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465919046055/0001104659-19-046055-index.htm | ||
| 2020-05-18 | Jeffrey T Barber | Director | Buy | 1,324.00 | 14,479.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064312/0001104659-20-064312-index.htm | ||
| 2020-08-13 | Michael J. Bonello | EVP & CFO | Sell | 2,052.00 | 102.88 | 211,109.76 | 21,276.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920096108/0001104659-20-096108-index.htm |
| 2020-04-27 | Michael J. Bonello | EVP & CFO | Sell | 3,672.00 | 87.97 | 323,025.84 | 23,328.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920052387/0001104659-20-052387-index.htm |
| 2018-06-21 | Alexander George Dickinson | Director | Buy | 1,307.00 | 2,397.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918042047/0001104659-18-042047-index.htm | ||
| 2018-01-16 | LINDA BADDOUR | Executive VP & CFO | Sell | 64,405.00 | 90.26 | 5,813,195.30 | 2,595.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm |
| 2019-08-13 | Michael J. Bonello | EVP & CFO | Buy | 9,000.00 | 27,000.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465919046967/0001104659-19-046967-index.htm | ||
| 2019-09-06 | Fund Holdings L.P. KKR | 10% Share Holder | Sell | 6,666,684.00 | 97.41 | 649,401,688.44 | 29,300.00 | https://www.sec.gov/Archives/edgar/data/1613859/000114036119016474/0001140361-19-016474-index.htm |
| 2019-09-06 | PRA Investors L.P. KKR | 10% Share Holder | Sell | 6,666,684.00 | 97.41 | 649,401,688.44 | 29,300.00 | https://www.sec.gov/Archives/edgar/data/1613859/000114036119016469/0001140361-19-016469-index.htm |
| 2018-08-16 | COLIN SHANNON | President & CEO | Buy | 30,000.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918052812/0001104659-18-052812-index.htm | ||
| 2020-05-18 | JAMES C MOMTAZEE | Director | Buy | 1,748.00 | 3,191.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064311/0001104659-20-064311-index.htm | ||
| 2020-08-13 | Christopher L Gaenzle | EVP, CAO & General Counsel | Sell | 1,364.00 | 102.88 | 140,328.32 | 37,636.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920096109/0001104659-20-096109-index.htm |
| 2019-06-03 | Alexander George Dickinson | Director | Buy | 1,436.00 | 3,833.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465919034064/0001104659-19-034064-index.htm | ||
| 2018-06-21 | Matthew P. Young | Director | Buy | 1,307.00 | 4,117.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918042050/0001104659-18-042050-index.htm | ||
| 2017-12-28 | David W Dockhorn | Executive Vice President & CCO | Sell | 68,614.00 | 90.81 | 6,230,837.34 | 4,236.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm |
| 2020-05-18 | Alexander George Dickinson | Director | Buy | 1,324.00 | 5,157.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064314/0001104659-20-064314-index.htm | ||
| 2019-06-03 | Matthew P. Young | Director | Buy | 1,436.00 | 5,553.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465919034065/0001104659-19-034065-index.htm | ||
| 2020-08-13 | COLIN SHANNON | President & CEO | Sell | 6,073.00 | 102.88 | 624,790.24 | 56,927.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920096111/0001104659-20-096111-index.htm |
| 2019-08-13 | COLIN SHANNON | President & CEO | Buy | 33,000.00 | 63,000.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465919046966/0001104659-19-046966-index.htm | ||
| 2018-06-21 | Linda S Grais | Director | Buy | 1,307.00 | 6,673.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918042049/0001104659-18-042049-index.htm | ||
| 2018-08-09 | Fund Holdings L.P. KKR | 10% Share Holder | Sell | 6,500,000.00 | 101.01 | 656,565,000.00 | 6,695,984.00 | https://www.sec.gov/Archives/edgar/data/1613859/000114036118036244/0001140361-18-036244-index.htm |
| 2018-08-09 | PRA Investors L.P. KKR | 10% Share Holder | Sell | 6,500,000.00 | 101.01 | 656,565,000.00 | 6,695,984.00 | https://www.sec.gov/Archives/edgar/data/1613859/000114036118036243/0001140361-18-036243-index.htm |
| 2018-01-16 | LINDA BADDOUR | Executive VP & CFO | Buy | 67,000.00 | 11.73 | 785,910.00 | 67,000.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm |
| 2020-05-18 | Matthew P. Young | Director | Buy | 1,324.00 | 6,877.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064309/0001104659-20-064309-index.htm | ||
| 2017-12-28 | David W Dockhorn | Executive Vice President & CCO | Buy | 72,850.00 | 11.73 | 854,530.50 | 72,850.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm |
| 2020-09-14 | Glen D. Stettin | Director | Buy | 799.00 | 799.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920105715/0001104659-20-105715-index.htm | ||
| 2019-06-03 | Linda S Grais | Director | Buy | 1,436.00 | 8,109.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465919034066/0001104659-19-034066-index.htm | ||
| 2020-05-18 | Linda S Grais | Director | Buy | 1,324.00 | 9,433.00 | https://www.sec.gov/Archives/edgar/data/1613859/000110465920064310/0001104659-20-064310-index.htm |